Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: Patient-Oriented Research Collaboration Grants - New/Early Career Investigators

University of British Columbia

$40,000.00

EmPOwER: Engaging Persons with cerebral venous thrombosis for meaningful Outcomes and peER support: A patient engagement initiative of the SECRET (Study of rivaroxaban for CeREbral venous Thrombosis) Trial

EF 2017-18

Résumé
Cerebral venous thrombosis (CVT), a deep venous clot in the draining veins around the brain, is a rare kind of stroke. Most patients affected are younger women: 75% are female and 80% are under the age of 50. Though outcomes after CVT have been considered as "excellent" as most people with the disease are able to return home and live independently, many have ongoing problems with fatigue, thinking, pain, mood and seizures that can significantly impact quality of life that are not always recognized or treated by physicians. We will hold patient meetings across the country to discuss issues after CVT and the path to recovery. This is also a chance for patients and family members to connect with each other. We will discuss the best ways to educate future patients and clinicians about CVT. We also want to make sure that patients with CVT are not isolated from research if they do not live in bigger cities. We will also help to connect people with CVT by establishing a website for information about the disease and for peer support.
Programme
Patient-Oriented Research Collaboration Grants - New/Early Career Investigators
Emplacement
British Columbia, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database

Tel que publié

Id
378486
Name
Field Thalia S
Region
British Columbia
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Circulatory and Respiratory Health
Theme2
Clinical
Prcname2
Patient Engagement - Collaboration Grants (SPOR)
Projecttitle
EmPOwER: Engaging Persons with cerebral venous thrombosis for meaningful Outcomes and peER support: A patient engagement initiative of the SECRET (Study of rivaroxaban for CeREbral venous Thrombosis) Trial
Programtype2
Operating Grants
Orgnameinp2
University of British Columbia
Cihramount2
$40,000
Cihrequipment2
$0
Programname2
Patient-Oriented Research Collaboration Grants - New/Early Career Investigators
Keyworddelim
Cerebral Venous Thrombosis; Patient-Oriented Outcomes; Prognosis; Stroke; Thrombosis
Abstract
Cerebral venous thrombosis (CVT), a deep venous clot in the draining veins around the brain, is a rare kind of stroke. Most patients affected are younger women: 75% are female and 80% are under the age of 50. Though outcomes after CVT have been considered as "excellent" as most people with the disease are able to return home and live independently, many have ongoing problems with fatigue, thinking, pain, mood and seizures that can significantly impact quality of life that are not always recognized or treated by physicians. We will hold patient meetings across the country to discuss issues after CVT and the path to recovery. This is also a chance for patients and family members to connect with each other. We will discuss the best ways to educate future patients and clinicians about CVT. We also want to make sure that patients with CVT are not isolated from research if they do not live in bigger cities. We will also help to connect people with CVT by establishing a website for information about the disease and for peer support.
Competitiondate
201711
Approvedterm2
1 yr 0 mth
Pinamesdelim
Field, Thalia S; Nadeau, Janel O
Approvedterm
1 an 0 mois
Cihrcontribution2
Patient Oriented Research~ $40,000~ $0~